Serum eosinophil cationic protein (sECP)in subjects with a history of asthma symptoms with or without rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 9, 1999, Pages 962-967

  Perfetti, L ^a   Galdi, E ^a   Brame B ^a   Speciale, L ^a   Moscato, G ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Asthma; Bronchial hyperresponsiveness; Eosinophil cationic protein (ECP); Eosinophils; Peak expiratory flow rate (PER); Spirometry; Symptoms

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHINITIS; SKIN TEST; SPIROMETRY;

ADOLESCENT; ADULT; AGED; ASTHMA; BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; RHINITIS; RIBONUCLEASES;

EID: 0032848835     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00023.x     Document Type: Article

References (32)

1. Sugai T, Sakiyama Y, Matumoto S, Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin Exp Allergy 1992;22:275-281.
2. Hoekstra MO, Hovenga H, Gerritsen J, Kauffman HF, Eosinophils and eosinophil-derived proteins in children with moderate asthma. Eur Respir J 1996;9:2231-2235.
3. Ferguson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995;95:23-28.
4. Scher H, Berman D, Weinberg EG, et al. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Clin Exp Allergy 1996;26:1131-1141.
5. Rao R, Frederick JM, Enander I, Gregson RK, Warner JA, Warner JO. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma, Clin Exp Allergy 1996;26:789-793.
6. Zimmerman B, Enander I, Zimmerman R, Ahlstedt S. Asthma in children less than five years of age: eosinophils and serum levels of cosinophil protein ECP and EPX in relation to atopy and symptoms. Clin Exp Allergy 1994;24:149-155.
7. Oymar K, Elsayed S, Bjerknes R, Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1996;7:180-186.
8. Koller DY, Wojnarowski C, Herkner KR, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma, J Allergy Clin Immunol 1997;99:752-756.
9. Björnsson E, Janson C, Hakansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994;49:730-736.
10. Parra A, Prieto I, Sanz ML, Diegucz I, Rosanu A, Oehling AK. Serum ECP levels in asthmatic patients: comparison with other follow-up parameters. Allergy Asthma Proc 1996;17:191-197.
11. Robinson DS, Assoufi B, Durham SR, Kay AB. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment, Clin Exp Allergy 1995;25:1118-1127.
12. 20, and exacerbations. Respir Med 1994;88:613-621.
13. Roquet A, Halldén G, Ihre E, Hed J, Zetterström O. Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma. Allergy 1996;51:482-488.
14. Beppu T, Ohta N, Gon S, et al. Eosinophil and eosinophil cationic protein in allergic rhinitis. Acta Otolaryngol (Stockh) 1994;Suppl 511:221-223.
15. Rasp G, Thomas PA, Bujia J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994;24:1151-1156.
16. Ciprandi G, Tosca M, Ricca V, et al. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activities. Clin Exp Allergy, 1997;27:1160-1166.
17. Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994;94:1310-1317.
18. Karawahczyk M, Paaksen K, Peterson CGB, Eklund E, Venge P. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin Exp Allergy 1995;25:713-719.
19. Schleimer RP, Bochner BS. The effect of glucocorticosteroids on human cosinophils. J Allergy Clin Immunol 1994;94:1202-1213.
20. National Heart, Lung and Blood Institute - WHO. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Publication no. 95-3659, Jan 1995.
21. Moscato G, Dellabianca A, Corsica A, Biscaldi GP, Gherson G, Vinci G. Bronchial responsiveness to ultrasonic "fog" in occupational asthma due to toluene diisocyanate (TDI). Chest 1993;104:1127-1131.
22. Dreborg S, editor. Skin tests used in type I allergy testing. Position paper. Allergy 1989;44 Suppl 10.
23. Tomassini M, Magrini L, De Petrillo G, et al. Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure. J Allergy Clin Immunol 1996;97:1350-1355.
24. Chivato T, Blasco R, Martinez D, et al. Eosinophil cationic protein and eosinophil protein X serum levels in allergic rhinitis and bronchial asthma. Allergy Clin Immunol News 1994;Suppl 2:361.
25. Ulrik CS. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy 1995;25:820-827.
26. Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. J Allergy Clin Immunol 1988;82:470-480.
27. Postma DS, Oosterhoff Y, Van Aalderen WMC, Kauffman HF, Wempe JB, Koeter GH. Inflammation in nocturnal asthma. Am J Respir Crit Care Med 1994;150:583-586.
28. Konno S, Gonokami Y, Kurokawa M, et al. Cytokine concentrations in sputum of asthmatic patients, Int Arch Allergy Immunol 1996;109:73-78.
29. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998;28:233-240.
30. Hoshino M, Nakamura Y. Relationship between activated eosinophils of the bronchial mucosa and serum eosinophil cationic protein in atopic asthma, Int Arch Allergy Immunol 1997;112:59-64.
31. O'Byrne PM, Hargreave FE. Non-invasive monitoring of airway inflammation. Am J Respir Crit Care Med 1994;150:5100-5102.
32. Wever AMJ, Wever-Hess J, Hermans J. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma. Clin Exp Allergy 1997;27:519-529.